Physician profile
Darryl D Cuda
NPI 1235114927
$4,975.28
in general payments reported to CMS, 2019-2025
17 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,654 · 2020: $31.25 · 2021: $29.72 · 2022: $248 · 2023: $1,454 · 2024: $230 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256 · Travel and Lodging: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.22 |
| Travel and Lodging | $755.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,118.32 | 2019 | |
| Treace Medical Concepts, INC. | $939.72 | 2023-2024 | |
| Medinc of Texas | $477.99 | 2019 | |
| Stryker Corporation | $359.59 | 2019-2023 | Fixos, Axsos, Augment Injectable |
| Acumed LLC | $297.26 | 2023-2025 | Acumed, Acumed |
| Novo Nordisk INC | $246.79 | 2025 | Wegovy |
| Sanara Medtech INC. | $192.35 | 2024 | Celleraterx |
| Davol INC. | $103.99 | 2022 | |
| Depuy Synthes Sales INC. | $100.00 | 2022 | |
| Medtronic, INC. | $36.21 | 2022-2023 | Ligasure |
| Bioventus LLC | $29.72 | 2021 | |
| Fidia Pharma USA INC. | $19.60 | 2023 | Hymovis, Triluron |
| Vericel Corporation | $15.23 | 2020 | |
| Theragen, INC. | $14.12 | 2022 | |
| Nvision Biomedical Technologies, INC. | $11.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $11.72 | 2024 | Magellan |
| Orthofix Medical, INC. | $0.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Cuda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.